A Phase 3 Randomized, Open Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects with Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency

Administered By

Awarded By

Contributors

Start/End

  • June 1, 2016 - April 30, 2018